Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The allegations made about the conception and establishment of the INTERGROWTH-21st research project are unfounded and without substance. Oxford University has its own robust internal review procedures which meet the highest academic standards on research conduct. Three separate investigations, in 2008, 2009 and 2011, have concluded there was no misconduct. These findings have been shared in detail with WHO, which has declared on three separate occasions that the matter is closed. The WHO’s recent review has not considered any material which has not already been thoroughly investigated by the University.

The results of the INTERGROWTH-21st Project have proved invaluable in highlighting the problems facing some of the most vulnerable infants in the world.  For example, a 2015 study by Johns Hopkins University concluded that 24% of all newborns in developing countries, assessed using the INTERGROWTH-21st Newborn Size Standards, are malnourished at birth. Hence, Oxford University is working closely with regional and country offices of WHO to disseminate the international standards arising from the project. 

In June 2016, WHO recommended the use of the INTERGROWTH-21st Newborn Size Standards to assess babies born to mothers who might have been infected with the Zika virus in pregnancy; these standards have also been adopted by CDC (Centers for Disease Control and Prevention).  In addition, this month, Sri Lanka became the first country in the world to adopt the INTERGROWTH-21st Postnatal Growth Standards for Preterm Infants.

Oxford University hopes to work further with WHO on the adoption of the project’s much-needed clinical tools and will vigorously defend the high standing and reputation of our researchers.

For further information, contact the News and Information Office on 01865 280528 or email news.office@admin.ox.ac.uk

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.